Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19

Bohan Jia, Junyi Sun, Di Zhu, Ling Wang, Xiaobo Hu, Haiyu Wang, Guowu Qian, Donghua Zhang, Silin Li, Hong Luo, Shixi Zhang, Guotao Li, Guangming Li, Hongxia Liang, Zujiang Yu, Zhigang Ren

Open source

DOI: 10.1038/s41598-025-85677-w
Published: 2025-03-31
Container: Scientific Reports
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-85677-w,
  title = {Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19},
  author = {Bohan Jia and Junyi Sun and Di Zhu and Ling Wang and Xiaobo Hu and Haiyu Wang and Guowu Qian and Donghua Zhang and Silin Li and Hong Luo and Shixi Zhang and Guotao Li and Guangming Li and Hongxia Liang and Zujiang Yu and Zhigang Ren},
  year = {2025},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-025-85677-w},
  url = {https://doi.org/10.1038/s41598-025-85677-w}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
AU  - Bohan Jia
AU  - Junyi Sun
AU  - Di Zhu
AU  - Ling Wang
AU  - Xiaobo Hu
AU  - Haiyu Wang
AU  - Guowu Qian
AU  - Donghua Zhang
AU  - Silin Li
AU  - Hong Luo
AU  - Shixi Zhang
AU  - Guotao Li
AU  - Guangming Li
AU  - Hongxia Liang
AU  - Zujiang Yu
AU  - Zhigang Ren
PY  - 2025
JO  - Scientific Reports
DO  - 10.1038/s41598-025-85677-w
UR  - https://doi.org/10.1038/s41598-025-85677-w
ER  -

APA

Jia, B., Sun, J., Zhu, D., Wang, L., Hu, X., Wang, H., Qian, G., Zhang, D., Li, S., Luo, H., Zhang, S., Li, G., Li, G., Liang, H., Yu, Z., & Ren, Z. (2025). Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19. Scientific Reports. https://doi.org/10.1038/s41598-025-85677-w

Source records

crossref · retrieved 2026-09-26T03:31:11.720Z